Location
Rockville, MD
Fiscal year end
December 31
Supernus Pharmaceuticals, Inc. has filed 1,085 SEC EDGAR filings since 3/6/2006
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Nov 14, 2024
SC 13G/A Report SC 13G/A Nov 1, 2024
SC 13G Report SEC SCHEDULE 13G Oct 31, 2024
SC 13G/A Report Feb 14, 2024
SC 13G Report SC 13G Feb 14, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report Jan 19, 2024
SC 13G/A Report Feb 14, 2023
SC 13G/A Report SCHEDULE 13G/A Feb 9, 2023
SC 13G/A Report Jan 23, 2023
SC 13G/A Report SC 13G/A Feb 15, 2022
SC 13G/A Report SCHEDULE 13G/A Feb 10, 2022
SC 13G/A Report Jan 27, 2022
SC 13G/A Report Jan 26, 2022
SC 13G/A Report Feb 16, 2021
SC 13G/A Report SCHEDULE 13G/A Feb 10, 2021
SC 13G Report Jan 25, 2021
SC 13G Report Mar 12, 2020
SC 13G/A Report SCHEDULE 13G/A Feb 12, 2020
SC 13G/A Report Feb 10, 2020
SC 13G/A Report Feb 11, 2019
SC 13G/A Report Jan 10, 2019
SC 13G Report Feb 9, 2018
SC 13G/A Report Jan 19, 2018
SC 13G/A Report Jan 17, 2017
SC 13G/A Report Oct 7, 2016
SC 13G/A Report ARDSLEY ADVISORY PARTNERS Feb 16, 2016
SC 13G Report Jan 28, 2016
SC 13G/A Report ARDSLEY ADVISORY PARTNERS Feb 17, 2015
SC 13G/A Report SC 13G/A Feb 17, 2015
SC 13G/A Report SUPN AS OF 12/31/2014 Feb 12, 2015
SC 13G/A Report SCHEDULE 13G Jan 22, 2015
SC 13G/A Report SUPN AS OF 07/31/2014 Aug 11, 2014
SC 13G/A Report SCHEDULE 13G AMENDMENT FILING Feb 14, 2014
SC 13G Report SC 13G Feb 13, 2014
SC 13G/A Report SUPN AS OF 12/31/2013 Feb 10, 2014
SC 13G/A Report Feb 7, 2014
SC 13G/A Report AMENDMENT NO. 1 Jan 16, 2014